Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian cancer- Allarity has received a Notice of Allowance for new...
-
LOS ANGELES, May 15, 2026 (GLOBE NEWSWIRE) -- XMax Inc. (NASDAQ: XWIN, “XMAX” or the Company), a distributor of contemporary styled residential and commercial furniture and artificial intelligence...
-
Commercial revenue increased 15% year over year, partially offsetting the anticipated residential slowdown in a post-25D market. Operating expenses declined 10% and interest expense fell 77% as the...
-
Ethos to present at upcoming investor conferences
-
Hikaru Kuribayashi, 17, of Sapporo, Japan won the $100,000 top award in the Regeneron International Science and Engineering Fair
-
Cemtrex Reports Fiscal Year 2026 Second Quarter Financial Results
-
Revenue of $2.7 million; Gross Profit of $2.2 million, Achieving Gross Margin of 80.7% Signed Non-Binding Letter of Intent to Acquire Assets of ConnectAndSell, Inc. ("ConnectAndSell"), Expected to...
-
BOCA RATON, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (Nasdaq: GNLN), a publicly traded company with a digital asset treasury strategy focused on...
-
CAMBRIDGE, Mass., May 15, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA®) platform to...
-
Completed Formal Dispute Resolution Meeting with FDA regarding Complete Response Letter (CRL) for ONS-5010; Decision Expected This Month Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe...